DCBCO-1303

N/A

Report date: 2025/01/26 18:40:48
NME

Base Information

Drug NameDCBCO-1303
Drug Alias NameSMO inhibitor (Development Center for Biotechnology)DCBCO-1303
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSmoothened receptor inhibitors
TargetsSmoothened receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDevelopment Center for Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesDevelopment Center for Biotechnology
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A